InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Tada Hiroomi. Insider active across 1 company, notably Tyra Biosciences, Inc.. Aggregated, 5 reports have been recorded. History available since 15 March 2022. The latest transaction was disclosed on 15 March 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Tada Hiroomi is a declarant, with 5 filings in total. The 5 sampled filings, from 2022-09-08 to 2024-03-19, are attributions linked to Tyra Biosciences, Inc., where the listed role is Chief Medical Officer, and the largest individual amounts are EUR 21058.23143442526, EUR 11896.523499472, EUR 11609.29167242933, EUR 8269.232224506683, and EUR 4692.483957108679.